ERK-regulated differential expression of the Mitf 6a/b splicing isoforms in melanoma

Pigment Cell and Melanoma Research

Volumn 23, Issue 1, 2010, Pages 93-102

  Primot, Aline ^a   Mogha, Ariane ^a   Corre, Sébastien ^a   Roberts, Karen ^b   Debbache, Julien ^a   Adamski, Henri ^c   Dreno, Brigitte ^d   Khammari, Amir ^d   Lesimple, Thierry ^e   Mereau, Agnes ^a   Goding, Colin R ^b,f   Galibert, Marie Dominique ^a,c  

^a UNIVERSITÉ DE RENNES 1   (France)

^b MARIE CURIE RESEARCH INSTITUTE   (United Kingdom)

^c RENNES UNIVERSITY HOSPITAL   (France)

^d NANTES UNIVERSITY HOSPITAL   (France)

^e CENTRE EUGÈNE MARQUIS   (France)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

MAPKinase pathway; Melanoma; Mitf; Splice form

Indexed keywords

B RAF KINASE; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1;

ANIMAL CELL; ARTICLE; CELL STIMULATION; GENE; MELANOMA; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR 6A GENE; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR 6B GENE; MOUSE; MUTATION; NONHUMAN; ONCOGENE N RAS; RNA SPLICING; SIGNAL TRANSDUCTION; SKIN METASTASIS;

ALTERNATIVE SPLICING; CELL LINE, TUMOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAP KINASE SIGNALING SYSTEM; MELANINS; MELANOCYTES; MELANOMA; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; PROTEIN ISOFORMS; SKIN NEOPLASMS; UP-REGULATION;

EID: 74349111358     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2009.00652.x     Document Type: Article

References (43)

1. Allemand, E., Batsche, E. Muchardt, C. (2008). Splicing, transcription, and chromatin: a menage a trois. Curr. Opin. Genet. Dev. 18, 145 151.
2. Armstrong (2004). Epidemiology of cutaneous melanoma and current trends. In : JF Thompson, DL Morton BBR Kroon, eds. Textbook of Melanoma London : Martin Dunitz Ltd pp. 65 80.
3. Bejar, J., Hong, Y. Schartl, M. (2003). Mitf expression is sufficient to direct differentiation of medaka blastula derived stem cells to melanocytes. Development 130, 6545 6553.
4. Bessard, A., Fremin, C., Ezan, F., Fautrel, A., Gailhouste, L. Baffet, G. (2008). RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo. Oncogene 27, 5315 5325.
5. Beuret, L., Flori, E., Denoyelle, C., Bille, K., Busca, R., Picardo, M., Bertolotto, C. Ballotti, R. (2007). Up-regulation of MET expression by alpha-melanocyte-stimulating hormone and MITF allows hepatocyte growth factor to protect melanocytes and melanoma cells from apoptosis. J. Biol. Chem. 282, 14140 14147.
6. Bhalla, U.S., Ram, P.T. Iyengar, R. (2002). MAP kinase phosphatase as a locus of flexibility in a mitogen-activated protein kinase signaling network. Science 297, 1018 1023.
7. Bismuth, K., Maric, D. Arnheiter, H. (2005). MITF and cell proliferation: the role of alternative splice forms. Pigment Cell Res. 18, 349 359.
8. Bloethner, S., Snellman, E., Bermejo, J.L., Hiripi, E., Gast, A., Thirumaran, R.K., Wellenreuther, R., Hemminki, K. Kumar, R. (2007). Differential gene expression in melanocytic nevi with the V600E BRAF mutation. Genes Chromosomes Cancer 46, 1019 1027.
9. Carreira, S., Goodall, J., Aksan, I., La Rocca, S.A., Galibert, M.D., Denat, L., Larue, L. Goding, C.R. (2005). Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression. Nature 433, 764 769.
10. Carreira, S., Goodall, J., Denat, L., Rodriguez, M., Nuciforo, P., Hoek, K.S., Testori, A., Larue, L. Goding, C.R. (2006). Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev. 20, 3426 3439.
11. Cronin, J.C., Wunderlich, J., Loftus, S.K. et al. (2009). Frequent mutations in the MITF pathway in melanoma. Pigment Cell Melanoma Res. 22, 435 444.
12. Du, J., Widlund, H.R., Horstmann, M.A., Ramaswamy, S., Ross, K., Huber, W.E., Nishimura, E.K., Golub, T.R. Fisher, D.E. (2004). Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF. Cancer Cell 6, 565 576.
13. Garraway, L.A., Widlund, H.R., Rubin, M.A. et al. (2005). Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436, 117 122.
14. Hemesath, T.J., Steingrimsson, E., McGill, G., Hansen, M.J., Vaught, J., Hodgkinson, C.A., Arnheiter, H., Copeland, N.G., Jenkins, N.A. Fisher, D.E. (1994). Microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev. 8, 2770 2780.
15. Hershey, C.L. Fisher, D.E. (2005). Genomic analysis of the microphthalmia locus and identification of the MITF-J/Mitf-J isoform. Gene 347, 73 82.
16. Hodgkinson, C.A., Moore, K.J., Nakayama, A., Steingrimsson, E., Copeland, N.G., Jenkins, N.A. Arnheiter, H. (1993). Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 74, 395 404.
17. Hoek, K.S., Eichhoff, O.M., Schlegel, N.C., Dobbeling, U., Kobert, N., Schaerer, L., Hemmi, S. Dummer, R. (2008). In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res. 68, 650 656.
18. van der Houven van Oordt, W., Diaz-Meco, M. T., Lozano, J., Krainer, A. R., Moscat, J. Caceres, J. F. (2000). The MKK(3/6)-p38-signaling cascade alters the subcellular distribution of hnRNP A1 and modulates alternative splicing regulation. J. Cell Biol. 149, 307 316.
19. Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J. Thun, M.J. (2007). Cancer statistics, 2007. CA Cancer J. Clin. 57, 43 66.
20. Loercher, A.E., Tank, E.M., Delston, R.B. Harbour, J. W. (2005). MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A. J. Cell Biol. 168, 35 40.
21. Mansky, K.C., Sankar, U., Han, J. Ostrowski, M.C. (2002). Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-kappa B ligand signaling. J. Biol. Chem. 277, 11077 11083.
22. Matter, N., Herrlich, P. Konig, H. (2002). Signal-dependent regulation of splicing via phosphorylation of Sam68. Nature 420, 691 695.
23. McGill, G.G., Horstmann, M., Widlund, H.R. et al. (2002). Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 109, 707 718.
24. McGill, G.G., Haq, R., Nishimura, E.K. Fisher, D.E. (2006). c-Met expression is regulated by Mitf in the melanocyte lineage. J. Biol. Chem. 281, 10365 10373.
25. Mereau, A., Anquetil, V., Cibois, M., Noiret, M., Primot, A., Vallee, A. Paillard, L. (2009). Analysis of splicing patterns by pyrosequencing. Nucleic Acids Res. 37, e126.
26. Miller, A.J., Levy, C., Davis, I.J., Razin, E. Fisher, D.E. (2005). Sumoylation of MITF and its related family members TFE3 and TFEB. J. Biol. Chem. 280, 146 155.
27. Moore, K. J. (1995). Insight into the microphthalmia gene. Trends Genet. 11, 442 448.
28. Murakami, H. Arnheiter, H. (2005). Sumoylation modulates transcriptional activity of MITF in a promoter-specific manner. Pigment Cell Res. 18, 265 277.
29. Rajan, P., Gaughan, L., Dalgliesh, C., El-Sherif, A., Robson, C.N., Leung, H.Y. Elliott, D.J. (2008). Regulation of gene expression by the RNA-binding protein Sam68 in cancer. Biochem. Soc. Trans. 36, 505 507.
30. Riker, A.I., Enkemann, S.A., Fodstad, O. et al. (2008). The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics. 1, 13.
31. Smith, C.W. Valcarcel, J. (2000). Alternative pre-mRNA splicing: the logic of combinatorial control. Trends Biochem. Sci. 25, 381 388.
32. Steingrimsson, E. (2008). All for one, one for all: alternative promoters and Mitf. Pigment Cell Melanoma Res. 21, 412 414.
33. Steingrimsson, E., Tessarollo, L., Pathak, B., Hou, L., Arnheiter, H., Copeland, N.G. Jenkins, N.A. (2002). Mitf and Tfe3, two members of the Mitf-Tfe family of bHLH-Zip transcription factors, have important but functionally redundant roles in osteoclast development. Proc. Natl. Acad. Sci. U.S.A. 99, 4477 4482.
34. Steingrimsson, E., Arnheiter, H., Hallsson, J.H., Lamoreux, M.L., Copeland, N.G. Jenkins, N.A. (2003). Interallelic complementation at the mouse mitf locus. Genetics 163, 267 276.
35. Tawbi, H.A. Kirkwood, J.M. (2007). Management of metastatic melanoma. Semin. Oncol. 34, 532 545.
36. Udono, T., Yasumoto, K., Takeda, K. et al. (2000). Structural organization of the human microphthalmia-associated transcription factor gene containing four alternative promoters. Biochim. Biophys. Acta 1491, 205 219.
37. Vance, K.W. Goding, C.R. (2004). The transcription network regulating melanocyte development and melanoma. Pigment Cell Res. 17, 318 325.
38. Vernet, C. Artzt, K. (1997). STAR, a gene family involved in signal transduction and activation of RNA. Trends Genet. 13, 479 484.
39. Wahl, M.C., Will, C.L. Luhrmann, R. (2009). The spliceosome: design principles of a dynamic RNP machine. Cell 136, 701 718.
40. Weg-Remers, S., Ponta, H., Herrlich, P. Konig, H. (2001). Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway. EMBO J. 20, 4194 4203.
41. Wellbrock, C., Rana, S., Paterson, H., Pickersgill, H., Brummelkamp, T. Marais, R. (2008). Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF. PLoS ONE 3, e2734.
42. Wu, M., Hemesath, T.J., Takemoto, C.M., Horstmann, M.A., Wells, A.G., Price, E.R., Fisher, D.Z. Fisher, D.E. (2000). c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev. 14, 301 312.
43. Xu, W., Gong, L., Haddad, M.M., Bischof, O., Campisi, J., Yeh, E.T. Medrano, E.E. (2000). Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9. Exp. Cell Res. 255, 135 143.